Letter/Replies
Reply
Kelly A. Diggs-Andrews PhD,
Kelly A. Diggs-Andrews PhD
Department of Neurology, Washington University School of Medicine, St Louis, MO
Search for more papers by this author Jacquelyn A. Brown PhD,
Jacquelyn A. Brown PhD
Department of Neurology, Washington University School of Medicine, St Louis, MO
Search for more papers by this author Scott M. Gianino MS,
Scott M. Gianino MS
Department of Neurology, Washington University School of Medicine, St Louis, MO
Search for more papers by this author Lucy D'Agostino McGowan MS,
Lucy D'Agostino McGowan MS
Department of Neurology, Washington University School of Medicine, St Louis, MO
Search for more papers by this author Joshua B. Rubin MD, PhD,
Joshua B. Rubin MD, PhD
Department of Pediatrics, Washington University School of Medicine, St Louis, MO
Search for more papers by this author David F. Wozniak PhD,
David F. Wozniak PhD
Department of Psychiatry, Washington University School of Medicine, St Louis, MO
Search for more papers by this author David H. Gutmann MD, PhD,
David H. Gutmann MD, PhD
Department of Neurology, Washington University School of Medicine, St Louis, MO
Search for more papers by this author
Kelly A. Diggs-Andrews PhD,
Kelly A. Diggs-Andrews PhD
Department of Neurology, Washington University School of Medicine, St Louis, MO
Search for more papers by this author Jacquelyn A. Brown PhD,
Jacquelyn A. Brown PhD
Department of Neurology, Washington University School of Medicine, St Louis, MO
Search for more papers by this author Scott M. Gianino MS,
Scott M. Gianino MS
Department of Neurology, Washington University School of Medicine, St Louis, MO
Search for more papers by this author Lucy D'Agostino McGowan MS,
Lucy D'Agostino McGowan MS
Department of Neurology, Washington University School of Medicine, St Louis, MO
Search for more papers by this author Joshua B. Rubin MD, PhD,
Joshua B. Rubin MD, PhD
Department of Pediatrics, Washington University School of Medicine, St Louis, MO
Search for more papers by this author David F. Wozniak PhD,
David F. Wozniak PhD
Department of Psychiatry, Washington University School of Medicine, St Louis, MO
Search for more papers by this author David H. Gutmann MD, PhD,
David H. Gutmann MD, PhD
Department of Neurology, Washington University School of Medicine, St Louis, MO
Search for more papers by this author
First published: 18 April 2014
No abstract is available for this article.
References
- 1Fisher MJ, Loguidice M, Gutmann DH, et al. Visual outcomes in children with neurofibromatosis type 1-associated optic pathway glioma following chemotherapy: a multicenter retrospective analysis. Neuro Oncol 2012; 14: 790–797.
- 1Diggs-Andrews KA, Brown JA, Gianino SM, et al. Sex is a major determinant of neuronal dysfunction in neurofibromatosis type 1. Ann Neurol 2014; 75: 309–316.
- 1Bajenaru ML, Hernandez MR, Perry A, et al. Optic nerve glioma in mice requires astrocyte Nf1 gene inactivation and Nf1 brain heterozygosity. Cancer Res 2003; 63: 8573–8577.
